m-squared pharmaceuticals

EUIPO EUIPO 2020 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark m-squared pharmaceuticals was filed as Figurative mark on 11/24/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/13/2021. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Backgrounds, in words or numerals, divided into two, three or four #Squares #One quadrilateral #Quadrilaterals with inscriptions projecting beyond one or more of the sides thereof #Quadrilaterals containing one or more rounded corners #Red, pink, orange #Black #Grey

Trademark Details Last update: February 9, 2024

Trademark form Figurative mark
File reference 018343098
Application date November 24, 2020
Publication date December 4, 2020
Entry date March 13, 2021
Expiration date November 24, 2030

Trademark owner

Strada per Cernusco 1
20060 Bussero (Milano)
IT

Trademark representatives

Via Senato, 8 20121 Milano (MI) IT

goods and services

1 Active chemical ingredients for use in the manufacture of pharmaceuticals; Reconstituted cells for the efficiency testing of pharmaceutical products; Reconstituted cells for the tolerance testing of pharmaceutical products; Stem cells for scientific purposes; Stem cells for research purposes; Stem cells for research or scientific purposes; Reconstituted cells for the tolerance testing of chemical products; Reconstituted cells for the efficiency testing of cosmetic products; Reconstituted cells for the tolerance testing of cosmetic products; Reconstituted cells for the efficiency testing of chemical products; Reconstituted cells for the tolerance testing of hygienic products; Chemical preparations for use in dna analysis [other than medical]; Cultures of microorganisms for industrial purposes; Cultures, other than for medical or veterinary use; Preservatives for maintaining the viability of micro-organisms in cultures [scientific]; Preservatives for maintaining the viability of micro-organisms in cultures [industrial]; Stem cells, other than for medical or veterinary purposes; Chemical reagents for use in genetic research; Genetic identity tests comprised of reagents; Tagged antibodies for scientific use; Monoclonal antibodies for scientific use; Monoclonal antibodies for industrial use; Tagged antibodies for laboratory use; Monoclonal antibodies for diagnostic use [other than medical]; Monoclonal antibody reagents, other than for medical use; Antibody reagents for scientific purposes; Proteins for detecting antibodies [other than for medical use]; Proteins for binding antibodies [other than for medical use]; Antibodies for scientific purposes, other than for medical or veterinary use; Monoclonal antibodies for use in the study of haematopoietic systems [other than for medical use]; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Reagents for use in the development of monoclonal antibodies [other than for medical or veterinary purposes]; Proteins for use in manufacture; Protein [raw material]; Proteins for use in science; Proteins for use in the manufacture of food supplements; Protein for use in the manufacture of cosmetics; Protein for food for human consumption [raw material]; Proteins for use in recombinant dna technology [other than for medical use]; Chemicals for use in the pharmaceutical industry; Preservatives for pharmaceutical preparations; Immunological antibodies, other than for medical use
5 Nutritional supplements; Vitamin and mineral supplements; Pharmaceutical drugs; Drug delivery agents that facilitate the delivery of pharmaceutical preparations; Pharmaceuticals; Chemico-pharmaceutical preparations; Pharmaceutical preparations for veterinary use; Stem cells; Cells for medical use; Stem cells for medical purposes; Stem cells for veterinary purposes; Pharmaceutical preparations containing stem cells; Living cells for medical use; Living cells for veterinary use; Surgical implants grown from stem cells; DNA synthesis inhibitors; Chemical preparations for use in dna analysis [medical]; Cultures for veterinary use; Cultures for medical use; Biological tissue cultures for medical purposes; Cultures of microorganisms for medical or veterinary use; Surgical implants grown from stem cells [living tissues]; Reagents for use in medical genetic testing; Antibodies; Human plasma protein; Regulatory proteins for medical use; Pharmaceutical compositions; Pharmaceutical preparations; Pharmaceuticals and natural remedies; Pharmaceutical preparations and substances; Chemicals for pharmaceutical use; Pharmaceutical preparations for human use; Medicine; Medical preparations; Medicated food supplements; Diagnostic substances for medical use; Biotechnological preparations for medical use; Biochemical preparations for medical use; Diagnostic agents for medical use; Culture media for medical use; Reagents for use in analysis [for medical purposes]; Chemical test reagents [medical]; Diagnostic chemical reagents for medical use
42 Pharmaceutical drug development services; Pharmaceutical products development; Research on the subject of pharmaceuticals; Testing of pharmaceuticals; Inspection of pharmaceuticals; Development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Stem cell research; Research and development in the field of microorganisms and cells; Scientific services relating to the isolation and cultivation of human tissues and cells; DNA screening for scientific research purposes; Genetic research; Genetic engineering services; Scientific research in the field of genetics and genetic engineering; Genetic mapping for scientific purposes; Scientific research relating to genetics; Laboratory research in the field of gene expression; Advisory services relating to gene therapy research; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies; Research and development services in the field of antibody technology; Pharmaceutical research and development; Scientific research in the field of pharmacy; Consultancy in the field of pharmaceutical research; Information technology services for the pharmaceutical and healthcare industries; Medical research
44 Advisory services relating to pharmaceuticals; Stem cell therapy services; Medical services relating to the removal, treatment and processing of stem cells; Medical services relating to the removal, treatment and processing of human cells; DNA screening for medical purposes; Drug, alcohol and DNA screening for medical purposes; Medical and health services relating to DNA, genetics and genetic testing; Stem cell storage; Genetic testing for medical purposes; Pharmaceutical advice; Pharmaceutical services

Trademark history

Date Document number Area Entry
December 14, 2023 Change Representative, Published

ID: 11018343098